Literature DB >> 25469991

Editorial: citrullination, and carbamylation, and malondialdehyde-acetaldehyde! Oh my! Entering the forest of autoantigen modifications in rheumatoid arthritis.

Erika Darrah1, Felipe Andrade.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25469991     DOI： 10.1002/art.38970

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  11 in total

Review 1.  Individuals at risk of seropositive rheumatoid arthritis: the evolving story.

Authors:  S Rantapää Dahlqvist; F Andrade
Journal:  J Intern Med       Date:  2019-10-21       Impact factor: 8.989

Review 2.  Obstructive lung diseases and risk of rheumatoid arthritis.

Authors:  H Maura Friedlander; Julia A Ford; Alessandra Zaccardelli; Alexsandra V Terrio; Michael H Cho; Jeffrey A Sparks
Journal:  Expert Rev Clin Immunol       Date:  2020-01-06       Impact factor: 4.473

Review 3.  Antibody-dependent and -independent mechanisms of inflammatory arthritis.

Authors:  Margaret H Chang; Peter A Nigrovic
Journal:  JCI Insight       Date:  2019-03-07

4.  Diagnostic performance of a new vimentin-derived ACPA (CCP high sensitive) in patients with rheumatoid arthritis.

Authors:  Daniel Bertin; Sylvain Dubucquoi; Daniela Lakomy; Anne-Sophie Deleplancque; Sophie Desplat-Jégo
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

5.  Pomegranate extract alleviates disease activity and some blood biomarkers of inflammation and oxidative stress in Rheumatoid Arthritis patients.

Authors:  M Ghavipour; G Sotoudeh; E Tavakoli; K Mowla; J Hasanzadeh; Z Mazloom
Journal:  Eur J Clin Nutr       Date:  2016-08-31       Impact factor: 4.016

6.  Immunogenic and inflammatory responses to citrullinated proteins are enhanced following modification with malondialdehyde-acetaldehyde adducts.

Authors:  Geoffrey M Thiele; Michael J Duryee; Carlos D Hunter; Bryant R England; Benjamin S Fletcher; Eric C Daubach; Taylor P Pospisil; Lynell W Klassen; Ted R Mikuls
Journal:  Int Immunopharmacol       Date:  2020-03-27       Impact factor: 4.932

7.  Disordered Antigens and Epitope Overlap Between Anti-Citrullinated Protein Antibodies and Rheumatoid Factor in Rheumatoid Arthritis.

Authors:  Zihao Zheng; Aisha M Mergaert; Lauren M Fahmy; Mandar Bawadekar; Caitlyn L Holmes; Irene M Ong; Alan J Bridges; Michael A Newton; Miriam A Shelef
Journal:  Arthritis Rheumatol       Date:  2019-12-10       Impact factor: 15.483

Review 8.  Redox-Mediated Carbamylation As a Hapten Model Applied to the Origin of Antibodies to Modified Proteins in Rheumatoid Arthritis.

Authors:  Maria Isabel Trejo-Zambrano; Eduardo Gómez-Bañuelos; Felipe Andrade
Journal:  Antioxid Redox Signal       Date:  2021-06-04       Impact factor: 7.468

Review 9.  Rheumatoid Arthritis-Associated Mechanisms of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans.

Authors:  Eduardo Gómez-Bañuelos; Amarshi Mukherjee; Erika Darrah; Felipe Andrade
Journal:  J Clin Med       Date:  2019-08-26       Impact factor: 4.241

Review 10.  Current view on the pathogenic role of anti-citrullinated protein antibodies in rheumatoid arthritis.

Authors:  Anca Catrina; Akilan Krishnamurthy; Bence Rethi
Journal:  RMD Open       Date:  2021-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.